arginine methyltransferase inhibitors (CellCentric)

N/A

Report date: 2025/03/18 18:06:45
NME

Base Information

Drug Namearginine methyltransferase inhibitors (CellCentric)
Drug Alias Namehistone methyl transferase inhibitor (Takeda Pharmaceutical)histone methyl transferase inhibitor (CellCentric)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-arginine N-methyltransferases inhibitors
TargetsProtein-arginine N-methyltransferases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellcentric Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A